- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Haemophilia A is a genetic deficiency caused by a lack of blood clotting factor VIII. Without enough factor VIII, the blood cannot clot properly to control bleeding. In the majority of cases, it is inherited as an X-linked recessive trait and usually affects men.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
Clotting Factor IXa and X |
Bispecific Antibody |
Hemlibra® |
30 mg/mL |
– |
2 mg |
-80°C |
09/2023 |
654,30 € |
||
Clotting Factor IXa and X |
Bispecific Antibody |
Hemlibra® |
30 mg/mL |
– |
2 mg |
-80°C |
08/2024 |
727,00 € |
||
Clotting Factor VIII |
Recombinant protein |
Advate® |
125 IU/mL |
– |
25 IU |
-80°C |
09/2022 |
414,90 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin